Swiss stocks - Factors to watch on Monday

Reuters
2025/12/22
Swiss stocks - Factors to watch on Monday

ZURICH/GDANSK, Dec 22 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:

HOLCIM HOLN.S

A court in Switzerland has decided to admit a legal complaint linked to global warming against Swiss cement maker Holcim which alleges the company is doing too little to cut carbon emissions, parties to the case said on Monday.

ROCHE ROG.S

Deals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new drugs in Switzerland, the CEO of Swiss pharma giant Roche ROG.S was quoted as saying on Saturday.

COMPANY STATEMENTS

* Novartis said on Friday novartis and the U.S. government had reached agreement on lowering drug prices in the U.S.

* Alcon said on Friday it had exercised right to require Staar Surgical to adjourn its special meeting of stockholders, now to be held January 6.

* Georg Fischer said on Friday it would propose candidacy of Ton Buechner to its board of directors at annual shareholders' meeting 2026.

ECONOMY

Swiss November money supply M3 due at 0800 GMT

SNB sight deposits due at 0900 GMT

(Reporting by Zurich newsroom and Gdansk newsroom)

((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10